Harun Muğlu, Erdem Sünger, Oğuzcan Özkan, Taha Koray Şahin, Bahadır Köylü, Kaan Helvacı, Yasemin Kemal, Umut Demirci, Fatih Selçukbiricik, Gül Başaran, Başak Oyan Uluç, Omer Fatih Olmez, Sercan Aksoy, Erhan Gökmen, Ahmet Bilici. "Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study." Scientific Reports, 2026. doi:10.1038/s41598-026-47351-7